Results 51 to 60 of about 715,161 (280)

The American College of Rheumatology Updated Recommended Methods for Development of Disease Classification and Response Criteria

open access: yesArthritis &Rheumatology, EarlyView.
Disease classification criteria and response criteria are important tools in the conduct of observational studies and clinical trials for rheumatic diseases. This paper updates methodologic guidance for classification and response criteria funded, developed and/or endorsed by the American College of Rheumatology (ACR), incorporating contemporary ...
Sindhu R. Johnson   +4 more
wiley   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia   +16 more
wiley   +1 more source

ANA, RF and CRP in Patients with Some of Rheumatic Symptoms

open access: yesمجلة بغداد للعلوم, 2005
one hundred three patients with rheumatic symptoms were included in this study and their sera tested for the presence of Antinuclear Antibody (ANA).
Wisal Salman Abd Mohsen
doaj   +1 more source

From Interferon Signature to the Clinical Landscape: Type I Interferonopathies

open access: yesArthritis &Rheumatology, EarlyView.
Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz   +13 more
wiley   +1 more source

Peripheral Blood DNA Methylation Changes Precede Lymphoma Diagnosis in Primary Sjögren's Disease

open access: yesArthritis &Rheumatology, EarlyView.
Objective Primary Sjögren's disease (SjD) is a systemic autoimmune disease associated with an increased risk of lymphoma. The molecular mechanisms underlying lymphomagenesis remain poorly understood, and sensitive biomarkers for early identification of patients at high risk of developing lymphoma are lacking.
Hanna Lidberg   +2 more
wiley   +1 more source

Artificial intelligence for automated classification of antinuclear-antibody indirect immunofluorescence patterns

open access: yesEULAR Rheumatology Open
: Objectives: This study aims to interpret antinuclear-antibody indirect immunofluorescence (ANA-IIF) patterns using a multistage deep learning (DL) classification framework.
Harsh Jain   +10 more
doaj   +1 more source

Application of Supervised Machine Learning to Recognize Competent Level and Mixed Antinuclear Antibody Patterns Based on ICAP International Consensus

open access: yesDiagnostics, 2021
Background: Antinuclear antibody pattern recognition is vital for autoimmune disease diagnosis but labor-intensive for manual interpretation. To develop an automated pattern recognition system, we established machine learning models based on the ...
Yi-Da Wu   +17 more
doaj   +1 more source

Synovial Tissue‐Guided Interleukin‐17A Inhibition for Refractory Arthritis in a Patient With Systemic Juvenile Idiopathic Arthritis

open access: yesArthritis &Rheumatology, Accepted Article.
Objective The objective of this study was to characterize the clinical, immunologic, and synovial tissue features of a patient with a systemic juvenile idiopathic arthritis (sJIA) who carries a novel heterozygous STAT5B loss‐of‐function variant (p.Gln139Ter) and whose arthritis responded markedly to interleukin‐17A (IL‐17A) inhibition.
Indira Sriram   +14 more
wiley   +1 more source

Systemic lupus erythematosus and nephritis: severe relapse with disappearance of antinuclear antibodies.

open access: yes, 2016
Exacerbations of systemic lupus erythematosus with active renal disease are almost always associated with high plasma titres of antinuclear factor (ANF) and DNA-binding antibody (anti-ds DNA).

core   +1 more source

Detection of Specific Autoantibodies in Sera with Negative Antinuclear Antibody by Indirect Immunofluorescence Assay but Positive by Enzyme Immunoassay

open access: yesSiriraj Medical Journal, 2019
Objective: The aim of this study was to investigate the predictive value of positive enzyme immunoassay (EIA) for detection of specific autoantibodies in sera negative for antinuclear antibody (ANA) by indirect immunofluorescence (IIF) assay, but ...
Ronnachai Viriyataveekul, M.D.   +1 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy